We are told that it is very common for cancer patients to acquire fungal infections during the course of their illness. I have wondered for decades if traditional medicine isn’t putting the proverbial cart before the horse when it comes to diagnosing and treating cancer.
Now comes a paper from healthline (1) that asks what the most common fungal infections that leukemia patient get. Acute myeloid leukemia (AML) is a cancer of the bone marrow and blood. Symptoms of loss of appetite, weight loss, night sweats, fever, fatigue plague AML patients. A few years ago, a paper posted on Ash Publications (2) stated that between 12-24% of patients being treated for their cancers will develop invasive fungal infections, the two most common being Aspergillus and Candida. Drs contend that since immunosuppressive drugs are used to treat AML, fungi thrive inside these patients when chemotherapy causes their immunity to dip. But think about this.
Doctors do not routinely test cancer patients for fungus. What if 12-24% of these AML patients presented to a cancer doctor with Candida or Aspergillus fungal infections? They’d never know, would they? But as immune declining therapy was initiated, these fungi would quickly surface! Additionally, these fungal infections could cause each of the “AML cancer” symptoms mentioned above. Sporanox (itraconazole) has been an effective antifungal drug (3) for AML patients in preventing fungal dissemination while undergoing chemotherapy.
Aspergillus species fungi make poisonous and invisible byproducts (mycotoxins) that can and do mimic cancer (4). Diagnostic errors occur when fungal infections are seen as “cancer” (5).
All of this said, Oncologists are not schooled in the study of fungus (mycology). Therefore, the onus is on the cancer patient to carefully review mold/fungal exposure prior to their “cancer” diagnosis. A history of excessive antibiotic or alcohol use could prompt a misdiagnosis. Living in a mold filled house could also enable systemic fungal growth that might be misdiagnosed. Share this information with the diagnosing doctor, as it could be lifesaving.
2. Ash Publications: Incidence of Invasive Fungal Infections in Acute Leukemia Patients Utilizing Micafungin Prophylaxis Compared to Second-Generation Azole Prophylaxis | Blood | American Society of Hematology (ashpublications.org)
4. PubMed.gov: https://pubmed.ncbi.nlm.nih.gov/29794965/